Impact of postoperative complications on recurrence in pathological stage II/III gastric cancer patients who received curative resection followed by adjuvant S-1 chemotherapy.

Authors

null

Hayato Watanabe

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan

Hayato Watanabe , Tsutomu Hayashi , Keisuke Koumori , Kazuki Kano , Yota Shimoda , Hirohito Fujikawa , Takanobu Yamada , Yasushi Rino , Munetaka Masuda , Takashi Ogata , Takashi Oshima

Organizations

Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan, Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan, Kanagawa Cancer Center, Yokohama, Japan, Yokohama City University, Yokohama, Japan, Department of Surgery, Yokohama City University, Yokohama, Japan

Research Funding

No funding received
None

Background: Postoperative complications increased recurrence in gastric cancer (GC) patients. However, there was no study evaluating impact of postoperative complication among patients receiving adjuvant chemotherapy. The aim of present study was to investigate the impact of postoperative complications in pStage II/III GC patients who received adjuvant S-1 chemotherapy. Methods: The present study retrospectively examined GC patients who received curative gastrectomy followed by adjuvant S-1 chemotherapy between January 2000 and December 2011 at Kanagawa Cancer Center. The patients with postoperative complications were classified into PC group, and those without postoperative complications were into NC group. Clinicopathological characteristics and recurrence-free survival (RFS) were compared between the groups. Results: 226 patients were included in this study. Postoperative complication occurred in 30 patients (13.3%). Age (Median, range) is significantly higher in NC group (64, 24-86) than in PC group (59, 36-82) (p = 0.033). Total gastrectomy was predominant type of surgery in the PC group (73.3%) than in NC group (52.0%) (p = 0.031). There was no difference in gender, ASA score, tumor location, pathological stage (TNM 7th) and pathological type between two groups. Conclusions: Postoperative complications were an independent risk factor for RFS in pStage II/III GC patients who received curative gastrectomy followed by adjuvant S-1 chemotherapy.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 320)

Abstract #

320

Poster Bd #

B17

Abstract Disclosures